These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21340131)

  • 1. [Aluminium in chronic renal replacement therapy patients undergoing haemodialysis in two renal units in Bogotá].
    Cárdenas O; Segura O; Puentes W; Sanabria M; Nava G; Torrenegra R
    Rev Salud Publica (Bogota); 2010 Aug; 12(4):669-81. PubMed ID: 21340131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum aluminium level in the veneto chronic haemodialysis population: cross-sectional study on 1,026 patients.
    Piccoli A; Andriani M; Mattiello G; Nordio M; Modena F; Dalla Rosa C
    Nephron; 1989; 51(4):482-90. PubMed ID: 2787000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum and dialysate aluminium concentration of dialysed patients with chronic renal failure determined by atomic absorption spectrometry with a graphite furnace.
    Mazzeo-Farina A; Cerulli N
    Clin Chim Acta; 1985 Apr; 147(3):247-54. PubMed ID: 3995774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Determination of the plasma aluminum concentration of hemodialysis patients].
    Kuleva V; Petrov I; Antonov S; Kiriakov Z
    Vutr Boles; 1984; 23(2):51-5. PubMed ID: 6741112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma aluminium: a redundant test for patients on dialysis?
    Gault PM; Allen KR; Newton KE
    Ann Clin Biochem; 2005 Jan; 42(Pt 1):51-4. PubMed ID: 15802033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silicon and aluminium interactions in haemodialysis patients.
    Parry R; Plowman D; Delves HT; Roberts NB; Birchall JD; Bellia JP; Davenport A; Ahmad R; Fahal I; Altmann P
    Nephrol Dial Transplant; 1998 Jul; 13(7):1759-62. PubMed ID: 9681724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum aluminium measurement by DC plasma emission spectrometry.
    Roberts NB; Williams P
    Ann Clin Biochem; 1988 Mar; 25 ( Pt 2)():169-75. PubMed ID: 3382147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aluminium in water for preparation of dialysate and in serum of dialysed patients.
    Blanusa M; Prester L; Crnogorac M; Puretić Z; Bubić-Filipi L; Dadić Z
    Arh Hig Rada Toksikol; 1997 Jun; 48(2):197-204. PubMed ID: 9434431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Initial evaluation of aluminum concentrations in patients with nephropathy and undergoing hemodialysis at the Miguel Pérez Carreño Hospital and the University Hospital of Caracas (Venezuela)].
    Parra OE; Navarro JA; de Ardila M; Weissinger J; Domínguez J; Gutiérrez LE; Carlini R; Mendoza JA; Salgado OJ; Romero RA
    Invest Clin; 1989; 30(4):193-203. PubMed ID: 2488708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect on serum aluminium levels of continued ingestion of aluminium gels by patients with chronic renal insufficiency (author's transl)].
    Boukari M; Rottembourg J; Jaudon MC; Clavel JP; Legrain M; Galli A
    Nouv Presse Med; 1978 Jan; 7(2):85-8. PubMed ID: 349501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aluminum, zinc and copper concentrations in plasma in chronic renal insufficiency.
    Zumkley H; Bertram HP; Lison A; Knoll O; Losse H
    Clin Nephrol; 1979 Jul; 12(1):18-21. PubMed ID: 477052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of oral aluminium therapy on plasma aluminium levels in patients with chronic renal failure in an area with low water aluminium.
    Fleming LW; Stewart Wk; Fell GS; Halls DJ
    Clin Nephrol; 1982 May; 17(5):222-7. PubMed ID: 7094439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Level-dependent inhibitory effect of hyperaluminaemia on parathyroid hormone secretion in patients with end-stage renal failure.
    Fernández E; Amoedo ML; Montoliu J
    Eur J Med; 1992 Dec; 1(8):482-4. PubMed ID: 1341207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of serum aluminium monitoring in dialysis patients: a multicentre study.
    D'Haese PC; Clement JP; Elseviers MM; Lamberts LV; Van de Vyver FL; Visser WJ; De Broe ME
    Nephrol Dial Transplant; 1990; 5(1):45-53. PubMed ID: 2109284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trace Metals' abnormalities in hemodialysis patients: relationship with medications.
    Lee SH; Huang JW; Hung KY; Leu LJ; Kan YT; Yang CS; Chung Wu D; Huang CL; Chen PY; Chen JS; Chen WY
    Artif Organs; 2000 Nov; 24(11):841-4. PubMed ID: 11119069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-response relationships in aluminium toxicity in humans.
    Coulson JM; Hughes BW
    Clin Toxicol (Phila); 2022 Apr; 60(4):415-428. PubMed ID: 35179097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum aluminium in haemodialysis patients: relation to osteodystrophy, encephalopathy and aluminium hydroxide consumption.
    Heaf JG; Nielsen LP
    Miner Electrolyte Metab; 1984; 10(6):345-50. PubMed ID: 6503890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum aluminium concentration and aluminium deposits in bone in patients receiving haemodialysis.
    Charhon SA; Chavassieux PM; Meunier PJ; Accominotti M
    Br Med J (Clin Res Ed); 1985 Jun; 290(6482):1613-4. PubMed ID: 3924189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Aluminum concentration in blood of hemodialysis patients and its clinical importance].
    Skarupskiene I; Kuzminskis V; Abdrachmanovas O; Ryselis S; Smalinskiene A; Naginiene R
    Medicina (Kaunas); 2003; 39 Suppl 1():104-8. PubMed ID: 12761430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of aluminium exposure through dialysis fluids. Analysis of changes in the last 8 years.
    Fernández-Martín JL; Canteros A; Serrano M; González-Carcedo A; Díaz-Corte C; Cannata Andía JB
    Nephrol Dial Transplant; 1998; 13 Suppl 3():78-81. PubMed ID: 9568827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.